Accessibility Menu
Synairgen Plc logo

Synairgen Plc(LSE) SNG

This security has been delisted. This page is retained for historical reference.

Synairgen Plc last closing stock price
MetricPriceDate
Last closeGBX 0.952025-04-08
Synairgen Plc stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-0.11%GBX 0.952025-04-01
1 month-52.5%GBX 2.002025-03-07
3 month-50%GBX 1.902025-01-08
Year to date-64.81%GBX 2.702024-12-31
1 year-77.16%GBX 4.162024-04-08
3 year-94.25%GBX 16.522022-04-08
5 year-97.65%GBX 40.342020-04-09
Since inception-99.15%GBX 1.122004-10-26

SNG News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

SNG Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-51.06%

Return on Capital

-81.31%

Return on Assets

-59.12%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

-£148.00K

Operating Income

-£15.72M

EBITDA

-£14.88M

Operating Cash Flow

-£19.14M

Capital Expenditure

-£61.01K

Free Cash Flow

-£19.20M

Cash & ST Invst.

£8.59M

Total Debt

£0.00

Synairgen Plc Performance Analysis

Synairgen Plc annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-12-31GBP 0N/A
20222022-12-31GBP 0N/A
20232023-12-31GBP 0N/A
20242024-12-31GBP 0N/A
Synairgen Plc sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42022-12-31N/A
Q22023-06-30N/A
Q42023-12-31N/A
Q22024-06-30N/A
Synairgen Plc annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-12-31GBP -0.24N/A
20222022-12-31GBP -0.09-63.9%
20232023-12-31GBP -0.04-52.3%
20242024-12-31GBP -0.03-19.1%
Synairgen Plc sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42022-12-3157.8%
Q22023-06-309.2%
Q42023-12-3122.9%
Q22024-06-3011.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2024YOY CHG

Revenue

£0.00

N/A

Gross Profit

-£14.00K

+73.1%

Gross Margin

0.00%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

36

N/A

Net Income

-£3.26M

+73.7%

EBITDA

-£3.65M

+73.8%

Quarterly Fundamentals

Name
Q2 2024YOY CHG

Total Cash

£8.59M

-52.3%

Total Debt

£0.00

N/A

Accounts Receivable

£1.93M

+172.1%

Inventory

£0.00

+100.0%

Long Term Debt

£0.00

N/A

Short Term Debt

£0.00

N/A

Return on Assets

-59.12%

N/A

Return on Invested Capital

-81.31%

N/A

Free Cash Flow

-£2.94K

+100.0%

Operating Cash Flow

-£2.92K

+100.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
NSCI.LNetScientific plc
£0.53-0.71%
AVO.LAdvanced Oncotherapy plc
£0.02-9.09%
DEST.LDestiny Pharma plc
£0.03-25.00%
TCF.LTheracryf Plc
£0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$92.32-0.08%
NOKNokia
$9.10-0.06%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
ONDSOndas
$7.80-0.02%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.